The CDC reduced the minimum age for RSV vaccination. Adults aged 50 to 59 with risk factors now qualify. The Advisory Committee on Immunization Practices, or ACIP, voted 14-0 in favor. One member voted to abstain.
The recommendation targets adults at high risk of severe RSV symptoms. Qualifying conditions include heart disease, diabetes, asthma, COPD, chronic bronchitis, kidney disease, weakened immunity, and neurological disorders. These health issues are common in people over 50.